« Targacept's Antidepressant Fails, And How |
| KV Pharmaceutical's Latest Makena Move »
November 8, 2011
In-Sourcing Chemistry: Lilly and AMRI
Here's an interesting release from Albany Molecular: they're announcing that they're hiring "more than 40" chemists to work at Eli Lilly's facilities in Indianapolis. They plan to hire them from the surrounding area - that is, I assume, that they plan to hire from the pool of people that Lilly has already let go.
This is interesting on several levels. I assume that AMRI's salaries and benefits are such that it's cheaper for Lilly to hire people this way than it is to hire them as Lilly employees. This is a technique (one could use the word "ploy", depending on one's vantage point) to get the work done without having to actually shell out for it. But then again, that's what outsourcing is, exactly, and this is outsourcing without going to China or India. Instead, the invoices are routed through exotic Albany, NY, while you get to have the chemists right there in front of you, with the corresponding improvements in communication and turnaround.
Thoughts? Is this the beginning of the on-shoring of chemical jobs - albeit at a lower level of compensation? Or is this just a desperate move by a company that's facing a hideous, hair-pulling patent cliff? Or both?
+ TrackBacks (0) | Category: Business and Markets
POST A COMMENT
- RELATED ENTRIES
- The Best Way to Halt a Clinical Trial
- Alkaline Lemons. Not a Misprint.
- Five Tons of TiCl4
- Nice Patent You Have There. . .
- Human Gene Editing
- Biogen's Alzheimer's Data
- Drug Development for Academics
- Ignoring the "No Loitering" Sign